- In October 2023, Precision Neuroscience Corporation expanded its operations by acquiring a manufacturing facility in Dallas. This facility will focus on producing key components for the company’s brain implants. The move is part of Precision Neuroscience's strategy to strengthen its manufacturing capabilities and support the growing demand for its advanced neural implant technologies
- In August 2023, Neuralink, a leading brain implant company, secured USD 280 million in funding to advance its U.S. FDA-approved technology. The investment will support the company’s efforts to further develop its neural implant solutions. Additionally, Neuralink plans to initiate human clinical trials in the near future, marking a significant step toward expanding its product's clinical applications
- In July 2021, Paradromics Inc. secured USD 20 million in funding from Prime Movers Lab and Westcott Investment Group. The company intends to leverage this investment to integrate neural science with medical device engineering. The funding will support Paradromics' efforts to develop innovative clinical therapies, advancing the potential of neural implants in treating various neurological conditions
